NEW YORK (GenomeWeb) – The US Food and Drug Administration has granted a CLIA waiver to Alere's respiratory syncytial virus infection panel, the firm announced today. The Alere i RSV test will be available in physicians' offices, hospital emergency rooms, and walk-in clinics throughout the US.

Alere said that it is the first molecular test that can be used at the point of care to detect RSV in 13 minutes or less, and that it is "significantly faster than conventional PCR tests."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.